Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-27Clinical Trial Update: Prevention of Nausea and Vomiting in Patients After Surgery [Phase 4]
Phase 4 clinical trial update from Yeditepe University Hospital on preventing postoperative nausea and vomiting, with the study status shown…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting [Phase 3]
This completed Phase 3 trial assessed the efficacy and safety of palonosetron for preventing postoperative nausea and vomiting across surger…
-
FDA approval · 2013-12-24FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for ondansetron from Hospira, Inc., a generic product. The approval confirms the supplemental filing…
-
FDA approval · 2013-12-24FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
The FDA documents a supplemental application for ondansetron submitted by Hospira, Inc., indicating an FDA regulatory action on this product…
-
FDA approval · 2013-12-20FDA Approved: METOCLOPRAMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic metoclopramide hydrochloride tablet under an original application from Heritage Pharmaceuticals (d/b/a Avet Pharmaceu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-12-19FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for ondansetron hydrochloride, a generic antiemetic used to prevent nausea and vo…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients [Phase 4]
Phase 4 trial evaluating a combination antiemetic regimen to prevent postoperative nausea and vomiting in breast surgery patients. The study…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012) [Phase 1]
Phase 1 trial evaluating the safety and tolerability of MK-0517 in healthy subjects. Results were posted in 2013.
-
FDA approval · 2013-12-10FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited, indicating an approved modifi…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting [Phase 4]
Phase 4 trial comparing aprepitant to ondansetron in preoperative triple-therapy for postoperative nausea and vomiting; results were posted …
-
FDA label_change · 2013-11-19FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
The FDA approved a Cumberland Pharmaceuticals supplemental application for SANCUSO (granisetron). The approval typically involves changes to…
-
CLINICAL_TRIALS research · 2013-11-15Clinical Trial Update: Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting [Phase 3]
Clinical trial update for Trimebutine Maleate (NEWBUTIN SR 300 mg) investigating postoperative nausea and vomiting in Phase 3; current statu…
-
CLINICAL_TRIALS withdrawal · 2013-11-14Clinical Trial Update: Developing Individualized Strategies to Prevent Nausea and Vomiting [NA]
A clinical trial evaluating individualized strategies to prevent postoperative nausea and vomiting has been withdrawn.
-
CLINICAL_TRIALS research · 2013-11-11Clinical Trial Update: Study to Evaluate Anxiety Sensitivity and Somatic Symptoms as Risk Factors for PONV
This clinical trial update notes a completed study assessing whether anxiety sensitivity and somatic symptoms are risk factors for postopera…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED) [Phase 2]
Phase 2 randomized trial evaluating rolapitant for prevention of postoperative nausea and vomiting has completed.
-
FDA approval · 2013-10-07FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ondansetron submitted by Sun Pharmaceutical Industries (ANDA077557). Ondansetron is a generic an…
-
FDA approval · 2013-09-19FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp under the ANDA.
-
FDA approval · 2013-09-19FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for METOCLOPRAMIDE from Teva Parenteral Medicines, Inc., for the approved generic product under ANDA…
-
FDA approval · 2013-09-19FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
The FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp under ANDA 076780, indicating an approved re…
-
CLINICAL_TRIALS research · 2013-09-19Clinical Trial Update: Acupuncture for Postoperative Nausea, Vomiting and Pain in Children: The Implication of Parental Attitudes [NA]
This ClinicalTrials.gov update notes the completion of a study examining acupuncture for postoperative nausea, vomiting, and pain in childre…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy [Phase 2, Phase 3]
The update summarizes completed Phase 2 and Phase 3 trials evaluating P6 acupressure for reducing postoperative nausea and vomiting in patie…
-
CLINICAL_TRIALS research · 2013-09-18Clinical Trial Update: Nasopharyngeal Packing and Rhinologic Surgery.
This entry provides an update on a clinical trial examining nasopharyngeal packing during rhinologic surgery. The trial status is currently …
-
FDA approval · 2013-08-30FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited to permit the marketing of thi…
-
CLINICAL_TRIALS withdrawal · 2013-08-12Clinical Trial Update: Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting [NA]
A clinical trial comparing oral aprepitant to intravenous ondansetron for preventing postoperative nausea and vomiting has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: 10% Carbohydrate Drink for Preventing Post-operative Nausea and Vomiting (PONV) After Spinal Morphine [Phase 1]
Phase 1 study evaluating whether a 10% carbohydrate drink can prevent postoperative nausea and vomiting after spinal morphine; the trial has…